FDA Approved: IRBESARTAN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original ANDA for Irbesartan, a generic angiotensin II receptor blocker. The approval allows Camber to market IRBESARTAN as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

ORIG AP for IRBESARTAN (IRBESARTAN)